Perrigo (PRGO) to Acquire Omega Pharma in ~$4.5B Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Goldman Sachs Comment on Perrigo's (PRGO) Omega Deal and Quarterly Results
November 6, 2014 2:21 PM ESTGoldman Sachs maintained a Neutral rating on Perrigo Co. (NYSE: PRGO) with a price target of $145. Earlier Perrigo reported Q1 results and announced a deal to acquire Omega. In the view of analyst Jami Rubin, Omega is a good strategic fit, but he noted Q1 was another weak quarter.
"While we dont take a view on the likelihood of the deal closing, strategically we think the deal makes sense and as it would provide PRGO with the geographic... More
Perrigo (PRGO) Misses Q1 EPS by 4c
November 6, 2014 6:33 AM ESTPerrigo (NYSE: PRGO) reported Q1 EPS of $1.40, $0.04 worse than the analyst estimate of $1.44. Revenue for the quarter came in at $951.5 million versus the consensus estimate of $997.9 million.
For earnings history and earnings-related data on Perrigo (PRGO) click here.
... More